This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cytosite Biopharma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Francisco A. Valenzuela: Innovator in Granzyme B Imaging and Therapy
Introduction
Francisco A. Valenzuela is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biomedical research, particularly in the area of immunotherapy. His work focuses on developing innovative solutions for imaging and treating immunoregulatory abnormalities.
Latest Patents
Valenzuela holds a patent for "Granzyme B directed imaging and therapy - Compounds of Formula (I) and Formula (II)." This patent describes compounds that are capable of binding to granzyme B. The pharmaceutical compositions derived from these compounds are designed for use in imaging granzyme B and treating various immunoregulatory conditions. He has 1 patent to his name.
Career Highlights
Valenzuela is associated with Cytosite Biopharma Inc., where he applies his expertise in developing therapeutic solutions. His innovative approach has positioned him as a key player in the field of immunotherapy.
Collaborations
He has collaborated with notable colleagues, including Hui Xiong and Kevin Michael Ruley, to advance research and development in his area of expertise.
Conclusion
Francisco A. Valenzuela's contributions to granzyme B imaging and therapy highlight his role as an influential inventor in the biomedical field. His work continues to pave the way for advancements in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile